FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule

 

Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.

Clinical Pharmacology Subcommittee Meeting of the Advisory Committee for Pharmaceutical Science

October 18-19, 2006

Jeffrey Barrett, Ph.D.

• 18 U.S.C. 208 waiver (pdf)

Edmund Capparelli, Pharm.D.

• 18 U.S.C. 208 waiver (pdf)

Marie Davidian, Ph.D.

• 18 U.S.C. 208 waiver (pdf)

Kathleen Giacomini, Ph.D.

• 18 U.S.C. 208 waiver (pdf)

William Jusko, Ph.D.

• 18 U.S.C. 208 waiver (pdf)

Jaap Mandema, Ph.D.

• 18 U.S.C. 208 waiver (pdf)

Jurgen Venitz, M.D.

• 18 U.S.C. 208 waiver (pdf)

Paul Watkins, Ph.D.

• 18 U.S.C. 208 waiver (pdf)


Page updated: September 27, 2006